Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug 1;202(3):455-457.
doi: 10.1164/rccm.202005-1654LE.

Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?

Tina Dutt  1 , David Simcox  1 , Colin Downey  2 , Daniella McLenaghan  1 , Charlotte King  1 , Manish Gautam  1 , Steven Lane  3 , Hassan Burhan  1
Affiliations
Comment

Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?

Tina Dutt et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

  • Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.
    Rappaport SH, Clark JM, Delibert S, Maynard KM, Prasad P, Kaufman DC, Pietropaoli AP, Quill CM, Groth CM. Rappaport SH, et al. Am J Respir Crit Care Med. 2020 Dec 15;202(12):1731-1733. doi: 10.1164/rccm.202006-2511LE. Am J Respir Crit Care Med. 2020. PMID: 32931713 Free PMC article. No abstract available.

Comment on

References

    1. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. - PMC - PubMed
    1. Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19) Version 1. 2020 [accessed 2020 Apr 5] Available from: https://www.preprints.org/manuscript/202002.0407/v1.
    1. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. - PMC - PubMed
    1. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150. - PMC - PubMed
    1. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089–1098. - PMC - PubMed